A panelist discusses how education and cost are key challenges in ensuring comprehensive molecular testing is performed in a timely manner for patients with ovarian cancer, emphasizing the need for ...

A new blood test detected 95% of homozygous SMN1 deletions, the cause of most SMA cases, with results available in about an ...

Urine tumour DNA testing identified recurrence risk and detected bladder cancer recurrence before clinical surveillance.

Scientists have directly observed how two negatively charged DNA molecules can pair up despite normally repelling each other.

Invivoscribe®, a global leader in precision diagnostics and measurable residual disease (MRD) testing, today announced that commercial shipments of the PrepQuant™ System have begun in North America.

Drs. Tina Lockwood and Stacy Gray share the newly released evidence-based guideline on circulating tumor DNA (ctDNA) testing from ASCO. They highlight recommendations on when ctDNA testing should be ...

Pragmatic, Multicenter, Double-Blind Evaluation of Circulating Cancer-Associated Macrophage-Like Cells for Detection of Cancer in Indeterminate Pulmonary Nodules A decision tree for molecular ...

Researchers at Dartmouth Hitchcock Medical Center have developed a way to diagnose Lyme disease earlier and more accurately than traditional testing methods. Over the past 30 years, Lyme disease has ...

Dental Practices Can Now Secure Priority Shipment for the Revolutionary Oral Cancer Molecular Diagnostic Test Ahead of ...

Normal-looking sperm can carry hidden DNA damage linked to recurrent pregnancy loss. It takes two sets of DNA to make a human ...